In this week’s edition of InnovationRx, we look at the battle for Metsera, the departure of FDA’s top drug regulator, Kimberly-Clark’s $40 billion Kenvue deal, and more.
We are in an AI Bubble: the big question is if this bubble will worth it for the physical infrastructure and coordinated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback